Drug Enforcement D-0515-2024

Lack of Assurance of Sterility

Status

Ongoing

Classification

Class II

Report Date

June 5, 2024

Termination Date

—

Product Information

Product description
Moxifloxacin 0.8 mg/0.8 mL Preservative-Free 0.8mL Single-Use vials for Intraocular Injection, Rx only, Imprimis NJOF, LLC. 1705 Route 46 West, unit 6B, Ledgewood, NJ 07852, NDC 71384-509-08
Product quantity
18,980 vials
Reason for recall
Lack of Assurance of Sterility
Recall initiation reason
—
Initial firm notification
—
Distribution pattern
Nationwide within the United States

Location & Firm

Recalling firm
Imprimis NJOF, LLC
Address
1705 Route 46 Ste 6B

United States
Voluntary / Mandated
Voluntary: Firm initiated
Status date
—

Codes & Dates

Recall number
D-0515-2024
Event ID
94551
Recall initiation date
May 14, 2024
Center classification date
May 29, 2024
Code info
Lot #: 23OCT013, Exp. Date 10/10/2024
More code info
—